Correlation Between MIRA Pharmaceuticals and Gilead Sciences

Can any of the company-specific risk be diversified away by investing in both MIRA Pharmaceuticals and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MIRA Pharmaceuticals and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MIRA Pharmaceuticals Common and Gilead Sciences, you can compare the effects of market volatilities on MIRA Pharmaceuticals and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MIRA Pharmaceuticals with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of MIRA Pharmaceuticals and Gilead Sciences.

Diversification Opportunities for MIRA Pharmaceuticals and Gilead Sciences

0.83

Correlation Coefficient

MIRA Pharmaceuticals  Gilead Sciences

Very poor diversification

The 3 months correlation between MIRA and Gilead is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding MIRA Pharmaceuticals Common and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and MIRA Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MIRA Pharmaceuticals Common are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of MIRA Pharmaceuticals i.e., MIRA Pharmaceuticals and Gilead Sciences go up and down completely randomly.

Pair Corralation between MIRA Pharmaceuticals and Gilead Sciences

Given the investment horizon of 90 days MIRA Pharmaceuticals Common is expected to generate 7.7 times more return on investment than Gilead Sciences. However, MIRA Pharmaceuticals is 7.7 times more volatile than Gilead Sciences. It trades about 0.05 of its potential returns per unit of risk. Gilead Sciences is currently generating about 0.02 per unit of risk. If you would invest  86.00  in MIRA Pharmaceuticals Common on February 26, 2024 and sell it today you would earn a total of  3.00  from holding MIRA Pharmaceuticals Common or generate 3.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

MIRA Pharmaceuticals Common  vs.  Gilead Sciences

MIRA Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in MIRA Pharmaceuticals Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, MIRA Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Gilead Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gilead Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with MIRA Pharmaceuticals and Gilead Sciences

The main advantage of trading using opposite MIRA Pharmaceuticals and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MIRA Pharmaceuticals position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.

The idea behind MIRA Pharmaceuticals Common and Gilead Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.